Merck’s Profits Explode as Government-Backed HPV Shot Gardasil Sales Skyrocket

Anthony Gucciardi
Natural Society
Tue, 01 Nov 2011 20:43 CDT
Mega drug manufacturer Merck & Co. is reporting a major increase in third-quarter profits due in part to the skyrocketing sales of death-linked HPV shot Gardasil – up 41 percent to $445 million thanks to government backing and a hugely successful yet deceptive ad campaigns targeted at unsuspecting parents and children. The overall value of Merck shares rose 80 cents, or 2.3 percent, to $35.11. The numbers are up from a year ago, when the company was hit with huge acquisition and legal charges. Of course behind the monetary surge in Gardasil sales is the horribly corrupt marketing and political techniques used to boost Merck out of economic downfall.When it comes to Gardasil, Merck is more concerned about pushing the shot on children and generating a profit than examining the true effects of the shot. Merck pushes Gardasil on children through omission of facts, political bribery, and blatant lies.

How could Merck sell Gardasil in such high quantities despite documentation linking it to 3,589 harmful reactions and 16 deaths between May 2009 and September 2010 alone? Well, Merck likes to pretend that the death link does not exist. Furthermore, Merck uses monetary incentive, also considered bribery, to ensure that Gardasil legislation is swiftly passed by key legislators. Because when it comes to generating profit, Merck has no concern for the health of the individual – especially the target demographic of boys and girls between the ages of 11 and 12.

In order to push Gardasil as a “safe” vaccine, Merck will go as far as to blatantly lie about the side effects of the HPV shot in magazine ads, website banner ads, and even on the official Gardasil website. In my special report on Gardasil ads, I documented how Merck supplements the real known side effects of Gardasil such as death and Guillain-Barre Syndrome for less threatening ones such as headache and nausea.

Speak Your Mind

*


*

Current ye@r *